IP Library Granted Patent US 9,259,334
Granted Patent B2
US 9,259,334 · App. 13/766,530 · Granted Feb 16, 2016

Scaffold system for tissue repair

Inventors: J. Jordan Massey Kaufmann (San Antonio, TX); C. Mauli Agrawal (San Antonio, TX); Steven R. Bailey (San Antonio, TX)
Assignee: Board of Regents of The University of Texas System
A61F2/82A61L27/34A61L27/50A61L27/507A61L27/56A61L27/58A61L31/10A61L31/14A61L31/146A61L31/148D04H1/4391D04H1/728A61F2/07A61L2430/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,259,334
App. No.
13/766,530
Granted
Feb 16, 2016
Kind
B2
Abstract

A device for treating a damaged tissue includes an expandable scaffold positionable in a portion of a luminal tissue structure of a mammal; and maintained via stent technology, wherein the scaffold is comprised of electrospun fibers composed of a biodegradable compound. The scaffold serves as a temporary template that allows the tissue to be rebuilt.

Claims (27)

1. A device for vascular tissue repair comprising:

a cell permeable diametrically expandable intraluminal scaffold composed of nonwoven fibers having an average porosity from about 70% to about 85%, a luminal surface comprising substantially curvilinear nonwoven fibers facing the lumen of the vascular tissue, and an abluminal surface comprising substantially linear fibers facing the luminal wall of the vascular tissue, wherein the scaffold has an ultimate tensile strength in the range of about 1.45±0.32 MPa to about 1.893±0.458 MPa.

2. The device of claim 1 , wherein the fibers are composed of biodegradable material and/or a bioresorbable material.

3. The device of claim 1 , wherein the scaffold is composed of on ore more poly(α-hydroxy esters).

4. The device of claim 1 , wherein scaffold is composed of polycaprolactone.

5. The device of claim 1 , wherein the scaffold is composed of natural polymers that are biodegradable and/or bioresorbable.

6. The device of claim 1 , wherein the scaffold is composed of elastin, collagen, DNA, RNA, glucosaminoglycans, polyhydroxyalkanoates or mixtures thereof.

7. The device of claim 1 , wherein the luminal surface is a concave surface and wherein the abluminal surface is a convex surface.

8. The device of claim 1 , wherein the scaffold is supported by a supporting structure.

9. The device of claim 8 , wherein the supporting structure is expandable.

10. The device of claim 8 , wherein the supporting structure is an expandable stent.

11. The device of claim 8 , wherein the supporting structure is a pliant structure.

12. The device of claim 8 , wherein the supporting structure is a repositionable structure.

13. The device of claim 8 , wherein the supporting structure is bioresorbable and/or biodegradable.

14. The device of claim 1 , wherein the scaffold is substantially tubular.

15. The device of claim 1 , wherein the scaffold is supported by at least a portion of a medical device.

16. The device of claim 1 , wherein the scaffold is sutured or mechanically affixed to a supporting structure.

17. The device of claim 1 , wherein the scaffold chemically adheres to a supporting structure.

18. The device of claim 1 , wherein a supporting structure is incorporated into the electrospun scaffold.

19. The device of claim 1 , wherein the fibers are treated with chemical or therapeutic agents or are treated with gas plasma.

20. A method of repairing vascular tissue comprising:

providing a cell permeable diametrically expandable intraluminal scaffold with an average porosity from about 70% to about 85% comprised of nonwoven fibers, a luminal surface of the intraluminal scaffold comprising substantially curvilinear fibers facing a lumen of the vascular tissue, and an abluminal surface comprising substantially linear fibers facing an interior wall of the vascular tissue, wherein the scaffold has an ultimate tensile strength in the range of about 1.45±0.32 MPa to about 1.893±0.458 MPa;

inserting the scaffold into a luminal area of the vascular tissue

expanding the scaffold such that the scaffold contacts at least a portion of the vascular tissue structure, wherein the scaffold is positioned such that the luminal surface of the scaffold provides attachment cell attachment surface while the abluminal surface allows for ingress and organization of cells; and

securing the scaffold in the vascular tissue structure.

21. The method of claim 20 wherein the vascular tissue structure of the inserting step is aneurysmal.

22. The method of claim 20 wherein the nonwoven fibers are comprised from a biodegradable material and/or a bioresorbable material.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2015
From: MASSEY KAUFMANN, J. JORDAN; AGRAWAL, C. MAULI; BAILEY, STEVEN R.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 036994/0082 →
Continuity (2)
Provisional Application 61598125 · Feb 13, 2012
Related Publication 20130218253A1 · Aug 22, 2013